HEMODYNAMIC CHANGES AT REST AND DURING EXERCISE IN LONG‐TERM CLONIDINE THERAPY OF ESSENTIAL HYPERTENSION
- 12 January 1974
- journal article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 195 (1-6) , 111-115
- https://doi.org/10.1111/j.0954-6820.1974.tb08106.x
Abstract
Thirteen men with untreated essential hypertension in WHO stage I, all working, have been studied ambulatorily. Oxygen consumption, heart rate, cardiac output (Cardiogreen) and intraarterial brachial pressure were recorded at rest in supine and sitting position and during steady state work at 300, 600 and 900 kpm/min. The subjects were treated with Clonidine as the sole drug for one year and the hemodynamic study was repeated. The reduction in the intraarterial pressure was usually due to a decrease in cardiac output which again was due to a reduction in heart rate. The calculated total peripheral resistance did not change significantly. The pressure reduction was greatest at rest. During submaximal exercise the differences between the hemodynamic parameters before and after therapy were small.Keywords
This publication has 13 references indexed in Scilit:
- Comparison of clonidine and methyldopa in hypertensive patients receiving a diuretic: A double-blind crossover studyThe American Journal of Cardiology, 1972
- HEMODYNAMIC CHANGES IN LONG‐TERM α‐METHYLDOPA THERAPY OF ESSENTIAL HYPERTENSIONActa Medica Scandinavica, 1972
- Clonidine: A new antihypertensive agentThe American Journal of Cardiology, 1971
- The effect of clonidine on hemodynamics in hypertensive patientsAmerican Heart Journal, 1971
- Hypotensive Action and Side Effects of Clonidine-Chlorthalidone and Methyldopa-Chlorthalidone in Treatment of HypertensionBMJ, 1970
- Treatment of Hypertension with ClonidineBMJ, 1970
- HEMODYNAMIC CHANGES IN LONG‐TERM DIURETIC THERAPY OF ESSENTIAL HYPERTENSIONActa Medica Scandinavica, 1970
- Pharmacodynamic Effects of a New Antihypertensive Drug, Catapres (ST-155)Circulation, 1969
- Analysis of the cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (Catapres)European Journal of Pharmacology, 1968
- Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HClEuropean Journal of Pharmacology, 1967